[1]World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report 2005. Gengeva:World Health Organization,2005. [2]全国结核病流行病学抽样调查技术指导组. 2000年全国结核病流行病学抽样调查报告.中国防痨杂志,2002,24(2):65-108.[3]Rosenkrands I, Aagaard C, Weldingh K, et al. Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis. Tuberculosis (Edinb),2008,88(4):335-343. [4]中华人民共和国卫生部. WS 288—2008肺结核诊断标准.北京:人民卫生出版社,2008.[5]中华人民共和国卫生部. 原发性肺癌诊疗规范(2011年版).北京:中华人民共和国卫生部,2011.[6]中华医学会呼吸病学分会.社区获得性肺炎诊断与治疗指南(草案).中华结核和呼吸杂志,1999,22(4):199-201.[7]Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole genome DNA microarray. Science, 1999, 284(5419):1520-1523. [8]Pym AS, Brodin P, Brosch R, et al. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol, 2002,46(3):709-717.[9]Gagneux S, DeRiemer K, Van T, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis Proc Natl Acad Sci U S A, 2006, 103(8):2869-2873. [10]Mattow J, Junqblut PR, Schaible UE, et al. Identfication of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains. Electrophoresis,2001,22(14):2936-2946. [11]Andersen AB, Hansen EB. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis. Infect Immun, 1989, 57(8):2481-2488. [12]Verbon A, Hartskeerl RA, Moreno C, et al. Characterization of B cell epitopes on the 16 K antigen of Mycobacterium tuberculosis. Clin Exp Immunol, 1992, 89(3):395-401.[13]Cocito C, Vanlinden F. Preparation and properties of antigen 60 from Mycobacterium bovis BCG. Clin Exp Immunol, 1986, 66(2):262-272.[14]刘忠华,丁元生,毕爱笑,等. 结核分枝杆菌38 kD-16 kD融合蛋白克隆表达及血清学诊断价值.中国防痨杂志,2009,31(10):564-568. |